Neonatal abstinence syndrome - Change in therapy options?;Neonatales Drogenentzugssyndrom - Wandel der Therapieoptionen?

Klinische Padiatrie

Volumn 225, Issue 5, 2013, Pages 243-244

  Gortner, L ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; INTRAUTERINE GROWTH RETARDATION; PRENATAL DRUG EXPOSURE; WITHDRAWAL SYNDROME;

FEMALE; HUMANS; MALE; NEONATAL ABSTINENCE SYNDROME; OPIOID-RELATED DISORDERS; OPIUM; ROOMING-IN CARE;

EID: 84883886445     PISSN: 03008630     EISSN: 14393824     Source Type: Journal    
DOI: 10.1055/s-0033-1354377     Document Type: Editorial

References (17)

1. Neonatal drug withdrawal American academy of pediatrics committee on drugs. Pediatrics: 1998; 101 1079 1088
2. Alex K., Feldmann R. Children and adolescents with fetal alcohol syndrome (FAS): better social and emotional integration after early diagnosis. Klin Padiatr: 2012; 224 66 71
3. Bandstra E. S., Morrow C. E., Mansoor E. et al. Prenatal drug exposure: infant and toddler outcomes. J Addict Dis: 2010; 29 245 258
4. Felderhoff-Muser U. Newborn Individualized Developmental Care and Assessment Program (NIDCAP): data with controversial evidence. Klin Padiatr: 2010; 222 234 235
5. Finnegan L. P., Connaughton J. F. Jr, Kron R. E. et al. Neonatal abstinence syndrome: assessment and management. Addict Dis: 1975; 2 141 158
6. Gaalema D. E., Scott T. L., Heil S. H. et al. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates. Addiction: 2012; 107 01 53 62
7. Gortner L. Comment on growth of term small-for-gestational-age and appropriate-for-gestational-age neonates during the first month of life. Klin Padiatr: 2011; 223 57 58
8. Hudak M. L., Tan R. C. Committee on Drugs et al Neonatal drug withdrawal. Pediatrics: 2012; 129 e540 e560
9. Huning B. M., Reimann M., Beerenberg U. et al. Establishment of a family-centred care programme with follow-up home visits: implications for clinical care and economic characteristics. Klin Padiatr: 2012; 224 431 436
10. Hunseler C., Bruckle M., Roth B. et al. Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience. Klin Padiatr: 2013; 225 247 251
11. Hunt R. W., Tzioumi D., Collins E. et al. Adverse neurodevelopmental outcome of infants exposed to opiate in-utero. Early Hum Dev: 2008; 84 29 35
12. McGlone L., Hamilton R., McCulloch D. L. et al. Neonatal visual evoked potentials in infants born to mothers prescribed methadone. Pediatrics: 2013; 131 e857 e863
13. Moll M., Schoning M., Golz R. et al. 2-year follow-up examinations (Bayley II) in infants born at <32 weeks in a German perinatal center. Klin Padiatr: 2011; 223 251 254
14. Muller M. J., Lange M., Paul T. et al. Breast feeding during methadon- and buprenorphin therapy. Klin Padiatr: 2011; 223 408 413
15. Patrick S. W., Schumacher R. E., Benneyworth B. D. et al. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA: 2012; 307 1934 1940
16. Poeschl J., Dabek M., Englert S. et al. Treatment of neonatal abstinence syndrome in preterm and term neonates. Klin Padiatr: 2013; 225 252 256
17. Roy J., Toubin R. M., Mazurier E. et al. Developmental outcome of 5-year-old children born to opiate-dependent mothers: effects of a multidisciplinary intervention during pregnancy. Arch Pediatr: 2011; 18 1130 1138